Carrato A, Gallego-Plazas J, Guillen-Ponce C.
Elche University Hospital, Elche (Alicante).
Multiple endocrine neoplasia: paediatric pers- pective.
J Pediatr Endocrinol Metab. 2005 Dec;18 Suppl 1:1237-44.
Rodriguez-Sanchez A, Lopez-Menchero C, Rodriguez-Arnao MD.
Unidad de Metabolismo y Desarrollo, Departamento de Pediatría, Hospital General Universitario Gregorio Marañón, Madrid.
Follow-up and risk of tumors in overgrowth syn- dromes.
J Pediatr Endocrinol Metab. 2005 Dec;18 Suppl 1:1227-35.
Gracia Bouthelier R, Lapunzina P.
Department of Pediatric Endocrinology, Hospital Universitario La Paz, Autónoma University, Madrid.
Usefulness of prostate-specific antigen nadir as predictor of androgen-independent progression of metastatic prostate cancer.
Int J Biol Markers. 2005 Oct-Dec;20(4):209-16.
Morote J, Esquena S, Abascal JM, Trilla E, Cecchini L, Raventos CX, Orsola A, Planas J, Catalan R, Reventos J.
Department of Urology, Vail d'Hebron University Hospital, Barcelona.
European multi-centre study on coeliac disease and non-Hodgkin lymphoma.
Eur J Gastroenterol Hepatol. 2006 Feb;18(2):187-194.
Luisa Mearin M, Catassi C, Brousse N, Brand R, Collin P, Fabiani E, Schweizer JJ, Abuzakouk M, Szajewska H, Hallert C, Farre Masip C, Holmes GK; on behalf of the Biomed Study Group on Coeliac Disease and Non-Hodgkin Lymphoma.
Departments of Paediatrics Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands. Department of Paediatrics, Amsterdam Free University Medical Center, Amsterdam, The Netherlands. Department of Paediatrics, University of Ancona, Ancona, Italy.
Department of Pathology, Necker-Enfants Malades Hospital, Paris V University, Paris, France. Departments of Internal Medicine, Hospital and Medical School, University of Tampere, Tampere, Finland. Department of Immunology, St James's Hospital and Trinity College, Dublin, Ireland. Department of Paediatric Gastroenterology and Nutrition, The Medical University of Warsaw, Warsaw, Poland.
public a ciones
Therapy of paraneoplastic pemphigus with Rituximab: a case report and review of literature.
J Eur Acad Dermatol Venereol. 2006 Jan;20(1):69-74.
Barnadas M, Roe E, Brunet S, Garcia P, Bergua P, Pimentel L, Puig L, Francia A, Garcia R, Gelpi C, Sierra J, Coll P, Alomar A.
Department of Dermatology, Hospital Sta. Creu i St. Pau, Barcelona.
Fixed dose-rate infusion of gemcitabine in combi- nation with cisplatin and UFT in advanced carci- noma of the pancreas.
Cancer Chemother Pharmacol. 2006 Jan 11;:1-8 Feliu J, Saenz JG, Jaraiz AR, Castanon C, Cruz M, Fonseca E, Lomas M, Castro J, Jara C, Casado E, Leon A, Baron MG.
Servicio de Oncología Médica, Hospital La Paz, Madrid.
Epigenetics provides a new generation of oncoge- nes and tumour-suppressor genes.
Br J Cancer. 2006 Jan 10.
Esteller M.
Cancer Epigenetics Laboratory, 3rd Floor, Molecular Pathology Programme, Spanish National Cancer Centre (CNIO), Madrid.
Primary cutaneous B-cell lymphoma (marginal zone) with prominent T-cell component and abe- rrant dual (T and B) genotype; diagnostic useful- ness of laser-capture microdissection.
Br J Dermatol. 2006 Jan;154(1):162-6.
Gallardo F, Pujol RM, Bellosillo B, Ferrer D, Garcia M, Barranco C, Planaguma M, Serrano S.
Department of Dermatology Laboratory of Cytogenetics and Molecular Biology, Hospital del Mar-Imas, Barcelona.
Adding pharmacogenomics to the development of new marine-derived anticancer agents.
J Transl Med. 2006 Jan 9;4:3.
Jimeno J, Aracil M, Tercero JC.
PharmaMar R & D, Madrid.
Profiling bladder cancer using targeted antibody arrays.
Am J Pathol. 2006 Jan;168(1):93-103.
Sanchez-Carbayo M, Socci ND, Lozano JJ, Haab BB, Cordon-Cardo C.
Tumor Markers Group, Molecular Pathology Programme Centro Nacional de Investiga-ciones Oncologicas, Madrid.
Adjuvant therapy of resected gastric cancer is necessary.
Semin Oncol. 2005 Dec;32(6 Suppl 9):105-8.
Publicaciones españolas indexadas en Medline
Publicaciones españolas indexadas en Medline desde el 15 de octubre hasta el 15 de enero de 2005
Department of Internal Medicine, Norrkoping Hospital, Norrkoping, Sweden. Department of Biochemistry, Hospital Sant Joan de Deu, Esplugues, Barcelona, Spain. Department of Gastroenterology, Derbyshire Royal Infirmary, Derby, UK.
Current status of follow-up of the upper digestive tract in familial adenomatous polyposis.
Gastroenterol Hepatol. 2006 Jan;29(1):15-21.
Spanish.
Pares D, Garcia-Ruiz A, Biondo S, Blanco I, Llort G, Arriol E, Oca J, Del Rio C, Osorio A, Navarro M, Marti-Rague J, Jaurrieta E.
Unidad de Cirugia Colorrectal. Servicio de Cirugia General y Digestiva. Hospital Universitari de Bellvitge. Barcelona.
Chronicles in drug discovery.
Drug News Perspect. 2005 Oct;18(8):517-22.
Khurdayan VK, Bozzo J, Prous JR.
Prous Science, Barcelona.
Tat8-TK/GCV suicide gene therapy induces pan- creatic tumor regression in vivo.
Hum Gene Ther. 2005 Dec;16(12):1377-88.
Cascante A, Huch M, Rodriguez LG, Gonzalez JR, Costantini L, Fillat C.
Programa Gens i Malaltia, Centre de Regulacio Genomica-CRG-UPF, Barcelona.
Correlations of telomere length, telomerase acti- vity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
Cancer. 2005 Dec 30.
Garcia-Aranda C, de Juan C, Diaz-Lopez A, Sanchez-Pernaute A, Torres AJ, Diaz-Rubio E, Balibrea JL, Benito M, Iniesta P.
Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad Complutense, Madrid.
Clinical evaluation of dental and periodontal sta- tus in a group of oncological patients before che- motherapy.
Med Oral Patol Oral Cir Bucal. 2006 Jan 1;11(1):E17-21. English, Spanish.
Lopez-Galindo MP, Bagan JV, Jimenez-Soriano Y, Alpiste F, Camps C.
University of Valencia.
Intestinal Transplantation in Children: Differences Between Isolated Intestinal and Composite Grafts.
Transplant Proc. 2005 Nov;37(9):4087-4088.
Lopez-Santamaria M, Gamez M, Murcia J, Leal N, Hernandez F, Tovar J, Frauca E, Camarena C,
public aciones
Department of Biochemistry and Molecular Biology, School of Medicine, University of Alcalá, Alcalá de Henares, Madrid.
Molecular protocol for HER2/neu analysis in breast carcinoma.
Clin Transl Oncol. 2005 Dec;7(11):504-511.
Verdu Artufel M, Colomer Valero A, Roman Llado R, Erill Sagales N, Calvo Llorca M, Moreno Carazo A, Cordon Cardo C, Puig Torrus X.
HISTOPAT Laboratoris. Barcelona.
Once-weekly dose of epoetinum alfa in cancer patients with anemia receiving radiotherapy.
Clin Transl Oncol. 2005 Dec;7(11):486-482.
Samper Ots PM, Rodriguez Perez A, Lopez Carrizosa C, Vallejo Ocana C, Dios Saez Garrido JD, Delgado Perez JM.
Servicio de Oncología Radioterápica. Hospital Central de la Defensa. Madrid.
Breast metastases.
Clin Transl Oncol. 2005 Nov;7(10):455-457.
Arribas Del Amo D, Santero Ramirez MP, Cordoba Diaz de Laspra E, Martinez Ubieto F, Corral Subias M, Cay Diarte A.
Servicio de Cirugía General. Hospital Comarcal de Alcañiz. Zaragoza.
Erythropoietin to treat anemia in cancer patients.
Med Clin (Barc). 2005 Dec 3;125(20):796.
Spanish.
Teresa Delgado-Macias M.
Facultad de Medicina. Departamento de Ciencias Médicas y Quirúrgicas. Santander.
Ocular infiltration in a patient with multiple mye- loma.
Arch Soc Esp Oftalmol. 2005 Dec;80(12):725-8.
Spanish.
Santos-Bueso E, Calvo-González C, Troyano J, Díaz-Valle D, Saiz M, Benitez-Del-Castillo JM, García-Sánchez J.
Unidad de Superficie e Inflamación Ocular, Servicio de Oftalmología, Hospital Clínico San Carlos, Madrid.
Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non- small-cell lung cancer: a Spanish Lung Cancer Group trial.
Ann Oncol. 2005 Dec 21;
Camps C, Massuti B, Jimenez A, Maestu I, Gomez RG, Isla D, Gonzalez JL, Almenar D, Blasco A, Rosell R, Carrato A, Vinolas N, Batista N, Giron CG, Galan A, Lopez M, Blanco R, Provencio M, Diz P, Felip E.
Consorcio Hospital General Universitario de Valencia, Valencia.
Androgen receptor CAG and GGC polymorp- hisms in Mediterraneans: repeat dynamics and population relationships.
J Hum Genet. 2005 Dec 20.
Esteban E, Rodon N, Via M, Gonzalez-Perez E, Santamaria J, Dugoujon JM, Chennawi FE, Melhaoui M, Cherkaoui M, Vona G, Harich N, Moral P.
Hierro L, de la Vega A, Diaz M, Bortolo G, Jara P, Molina M, Sarria J, Prieto G.
Unit of Pediatric Abdominal Organs
Transplantation, Department of Pediatric Surgery, Madrid.
Radiation therapy in simultaneous choroidal and brain metastases
An Med Interna. 2005 Sep;22(9):431-3. Spanish.
Conill C, Jorcano S, Planas I, Marruecos J, Casas F, Fontenla JR.
Servicio de Oncología Radioterápica, Hospital Clinic, Universidad de Barcelona, Barcelona.
Fruit and vegetable intake and the risk of sto- mach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
Int J Cancer. 2005 Dec 27.
Gonzalez CA, Pera G, Agudo A, Bueno-de- Mesquita HB, Ceroti M, Boeing H, Schulz M, Del Giudice G, Plebani M, Carneiro F, Berrino F, Sacerdote C, Tumino R, Panico S, Berglund G, Siman H, Hallmans G, Stenling R, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quiros JR, Allen N, Key TJ, Bingham S, Day NE, Linseisen J, Nagel G, Overvad K, Jensen MK, Olsen A, Tjonneland A, Buchner FL, Peeters PH, Numans ME, Clavel-Chapelon F, Boutron-Ruault MC, Roukos D, Trichopoulou A, Psaltopoulou T, Lund E, Casagrande C, Slimani N, Jenab M, Riboli E.
Department of Epidemiology, Catalan Institute of Oncology, Barcelona (ICO-IDIBELL).
{Delta}TAp73 Upregulation Correlates With Poor Prognosis in Human Tumors: Putative In Vivo Network Involving p73 Isoforms, p53, and E2F-1.
J Clin Oncol. 2005 Dec 27;
Dominguez G, Garcia JM, Pena C, Silva J, Garcia V, Martinez L, Maximiano C, Gomez ME, Rivera JA, Garcia-Andrade C, Bonilla F.
Department of Medical Oncology, Hospital Universitario Puerta de Hierro; Department of Surgery, Hospital Universitario Puerta de Hierro;
Department of Pathology, Hospital Santa Cristina, Madrid; and the Department of Pathology, Hospital Virgen de la Salud, Toledo.
Epigenetic silencing of E- and N-cadherins in the stroma of mouse thymic lymphomas.
Carcinogenesis. 2005 Dec 24.
Matabuena de Yzaguirre M, Santos Hernandez J, Fernandez Navarro P, Lopez Nieva P, Herranz M, Fraga MF, Esteller M, Juarranz A, Fernandez- Piqueras J.
Laboratorio de Genética Molecular Humana, Departamento de Biología, Universidad Autónoma de Madrid, Madrid.
Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin.
Apoptosis. 2005 Dec 21.
Sanchez AM, Sanchez MG, Malagarie-Cazenave S, Olea N, Diaz-Laviada I.
Department of Animal Biology-Anthropology, Faculty of Biology, University of Barcelona, Barcelona.
Intraclonal variability of VH genes in follicular lymphoma patients who have received anti- idiotypic immunotherapy.
J Immunother. 2006 Jan-Feb;29(1):61-6.
Yanez R, Barrios Y, Cabrera R, Diaz-Espada F.
Department of Immunology, Hospital Clinica Puerta de Hierro, Madrid.
Postoperative Surveillance in Patients With Colorectal Cancer Who Have Undergone Curative Resection: A Prospective, Multicenter, Randomized, Controlled Trial.
J Clin Oncol. 2005 Dec 19.
Rodriguez-Moranta F, Salo J, Arcusa A, Boadas J, Pinol V, Bessa X, Batiste-Alentorn E, Lacy AM, Delgado S, Maurel J, Pique JM, Castells A.
Gastroenterology Department, Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer, University of Barcelona (IDIBAPS), Barcelona.
Feasibility and tolerability of sequential doxoru- bicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy.
Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8715-21.
Gianni L, Baselga J, Eiermann W, Guillem Porta V, Semiglazov V, Lluch A, Zambetti M, Sabadell D, Raab G, Llombart Cussac A, Bozhok A, Martinez- Agullo A, Greco M, Byakhov M, Lopez Lopez JJ, Mansutti M, Valagussa P, Bonadonna G; European Cooperative Trial in Operable Breast Cancer Study Group.
Istituto Nazionale Tumori, Milan, Italy, and Hospital Vall d'Hebron, Barcelona.
The accumulation of specific amplifications cha- racterizes two different genomic pathways of evolution of familial breast tumors.
Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8577-84.
Melchor L, Alvarez S, Honrado E, Palacios J, Barroso A, Diez O, Osorio A, Benitez J.
Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Center, Madrid.
Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthase.
Carcinogenesis. 2005 Dec 16.
Santamaria G, Martinez-Diez M, Fabregat I, Cuezva JM.
Departamento de Biología Molecular, Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, Madrid.
Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid car- cinoma.
Surgery. 2005 Dec;138(6):1095-100, discussion 1100-1.
Dig Dis. 2005;23(2):151-5.
Sanz-Casla MT, Maestro ML, Vidaurreta M, Maestro C, Arroyo M, Cerdan J.
Servicio de Análisis Clínicos, Sección Biología Tumoral, Hospital Clínico San Carlos, Madrid.
Pancreatic cancer: therapeutical update An Med Interna. 2005 Aug;22(8):390-4.
Spanish.
Khosravi Shahi P, Diaz Munoz de la Espada VM.
Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid.
Differential expression of MHC class II molecules in highly metastatic breast cancer cells is media- ted by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development.
Int J Biochem Cell Biol. 2005 Nov 28.
Shi B, Vinyals A, Alia P, Broceno C, Chen F, Adrover M, Gelpi C, Price JE, Fabra A.
Institut de Recerca Oncologica (IDIBELL-IRO), Hospital Duran i Reynals, Hospitalet de Llobregat, Barcelona.
Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to pre- dict the outcome of patients.
Eur J Haematol. 2006 Jan;76(1):58-63.
Plancarte F, Lopez-Guillermo A, Arenillas L, Montoto S, Gine E, Muntanola A, Ferrer A, Villamor N, Bosch F, Colomo L, Balaguer O, Campo E, Montserrat E.
Department of Hematology, Hospital Clinic, Barcelona.
Ovarian cancer: is the news good enough?
Int J Gynecol Cancer. 2005 Nov-Dec;15 Suppl 3:298-306.
Poveda A.
Servicio de Oncología Médica, Fundación Instituto Valenciano de Oncología, Valencia.
Tetraplex DNA Transitions within the Human c- myc Promoter Detected by Multivariate Curve Resolution of Fluorescence Resonance Energy Transfer.
Biochemistry. 2005 Dec 20;44(50):16426-34.
Kumar P, Verma A, Maiti S, Gargallo R, Chowdhury S.
Institute of Genomics and Integrative Biology, CSIR, Mall Road, Delhi 110007, India, and Department of Analytical Chemistry, University of Barcelona, Barcelona.
Lack of Germ-line Mutations at the Specific BRCA1-IRIS Coding Sequence in 114 Spanish High-risk Breast/ovarian Families.
Fam Cancer. 2005;4(4):317-9.
Hoya Mde L, Fernandez JM, de Abajo AS, Tosar A, Diaz-Rubio E, Caldes T.
Laboratory of Molecular Oncology, Hospital Clínico San Carlos, Madrid.
Experience of 6 years with home enteral nutri- tion in an area of Spain.
Pereira JA, Jimeno J, Miquel J, Iglesias M, Munne A, Sancho JJ, Sitges-Serra A.
Department of Health Sciences, Universitat Pompeu Fabra, Barcelona.
FOLFOX alternated with FOLFIRI as first-line che- motherapy for metastatic colorectal cancer.
Clin Colorectal Cancer. 2005 Nov;5(4):263-7.
Aparicio J, Fernandez-Martos C, Vincent JM, Maestu I, Llorca C, Busquier I, Campos JM, Perez- Enguix D, Balcells M.
Servicio de Oncología Médica, Hospital Universitario La Fe, Valencia.
Near-total laryngectomy. Experience, complica- tions and acoustic analysis
Acta Otorrinolaringol Esp. 2005 Nov;56(9):423- 7. Spanish.
de Paula Vernetta C, de la Fuente Arjona L, Garcia Callejo FJ, Ramirez Sabio JB, Marco Algarra J.
Hospital Clínico Universitario de Valencia.
Cell cycle and apoptosis mechanisms implicated in intravesical chemotherapy resistances in superficial bladder cancer
Actas Urol Esp. 2005 Oct;29(9):846-59. Spanish.
Burgues Gasion JP, Pontones Moreno JL, Vera Donoso CD, Jimenez Cruz JF, Ozonas Moragues M.
Servicio de Urología, Hospital Universitario Son Dureta Palma de Mallorca, Hospital Universitario La Fe, Valencia.
Dose escalation with three dimensional confor- mal radiotherapy for prostate cancer: more is better?
Actas Urol Esp. 2005 Oct;29(9):834-41. Spanish.
Zapatero A, Marin A, Cruz-Conde A, Lopez MA, Minguez R, Garcia-Vicente F.
Servicios de Oncología Radioterápica, Hospital Universitario de la Princesa, Madrid.
Influence of climate, according to Koppen classifi- cation and Lang's index, on gross rate mortality associated with prostate cancer in the geographi- cal area of Spain
Actas Urol Esp. 2005 Oct;29(9):828-33. Spanish.
Santos Arrontes D, Fernandez Arjona M, Valer Lopez-Fando MP, Cortes Aranguez I.
Servicio de Urología, Hospital Santa Barbara, Puertollano, Ciudad Real.
Celecoxib induces anoikis in human colon carci- noma cells associated with the deregulation of focal adhesions and nuclear translocation of p130Cas.
Int J Cancer. 2005 Dec 13.
Casanova I, Parreno M, Farre L, Guerrero S, Céspedes MV, Pavón MA, Sancho FJ, Marcuello E, Trías M, Mangues R.
Laboratori d'Investigacio Gastrointestinal de l'Institut de Recerca of the Hospital de la Santa Creu i Sant Pau, Barcelona.
p16 Gene methylation in colorectal tumors:
correlation with clinicopathological features and prognostic value.
Eur J Clin Nutr. 2005 Dec 7;
de Luis DA, Aller R, Izaola O, Terroba MC, Cabezas G, Cuellar LA.
1Secc. de Endocrinologia Y Nutricion Clinica Hospital U. Rio Hortega, Valladolid, Spain.
2Instituto de Endocrinologia Y Nutricion (I.E.N) Facultad de Medicina, Valladolid, Spain. 3Unit of Investigation Valladolid, Valladolid, Spain.
Total laparoscopic radical trachelectomy with intraoperative sentinel node identification for early cervical stump cancer.
J Minim Invasive Gynecol. 2005 Nov- Dec;12(6):522-4.
Diaz-Feijoo B, Gil-Moreno A, Puig O, Martinez- Palones JM, Xercavins J.
Unit of Gynecologic Oncology, Department of Obstetrics and Gynecology, Hospital Materno- infantil Vall d'Hebron, Autonomous University of Barcelona, Barcelona.
Non-melanoma skin cancer in Catalonia. A com- munity-based prevalence study.
Int J Dermatol. 2005 Nov;44(11):922-4.
Estrada JG.
Hospital Comarcal de Sant Boi de Llobregat, Sant Boi de Llobregat, Barcelona.
Peripheral T-cell lymphoma with secondary epit- helioid granulomatous cutaneous involvement: a clinicopathologic study of four cases.
J Dermatol. 2005 Jul;32(7):541-8.
Pujol RM, Gallardo F, Servitje O, Marti RM, Bordes R, Garcia-Muret MP, Estrach MT, Nomdedeu JF.
Department of Dermatology and Pathology, Hospital del Mar-IMAS, Barcelona.
Weekly paclitaxel as second/third-line treatment in advanced non-small cell lung cancer patients:
efficacy and tolerability.
Anticancer Res. 2005 Nov-Dec;25(6C):4611-4.
Camps C, Caballero C, Blasco A, Safont MJ, Berrocal A, Garde J, Juarez A, Sirera R, Bremnes RM.
Servicio de Oncología Médica, Hospital General Universitario de Valencia, Valencia.
Hodgkin's lymphoma cells express alternatively spliced forms of HDM2 with multiple effects on cell cycle control.
Oncogene. 2005 Dec 5.
Sanchez-Aguilera A, Garcia JF, Sanchez-Beato M, Piris MA.
Lymphoma Group, Molecular Pathology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid.
Thalidomide and dexamethasone in patients with multiple myeloma not undergoing upfront autolo- gous stem cell transplantation.
Haematologica. 2005 Dec;90(12):1589.
Blade J.
Hematology Unit, IDIBAPS, Hospital Clinic, Barcelona.
Weekly docetaxel in patients with recurrent
public a ciones
Investigaciones Oncológicas (CNIO), Madrid.
Lack of deleterious effect on bone mineral den- sity of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma.
Endocr Relat Cancer. 2005 Dec;12(4):973-81.
Reverter JL, Holgado S, Alonso N, Salinas I, Granada ML, Sanmarti A.
Department of Endocrinology and Nutrition, Germans Trias i Pujol Hospital, Barcelona.
Rapid-infusion rituximab in lymphoma treat- ment.
Ann Oncol. 2005 Dec 1.
Provencio M, Cerdeira S, Bonilla F, Sanchez A, Espana P.
Servicio de Oncología Médica, Hospital Universitario Puerta de Hierro, Madrid.
Tissue imprints or primary cultures: which stra- tegy to use to study cytogenetic clonality?
Diagn Mol Pathol. 2005 Dec;14(4):243-6.
Nadal M, Pera G, Gomez-Zaera M, Abril J, Suarez JF, Aguilo F, Condom E, Nunes V.
Centre de Genetica Medica i Molecular, Institut de Recerca Oncologica, IDIBELL, Barcelona.
A novel logistic model based on clinicopathologi- cal features predicts microsatellite instability in colorectal carcinomas.
Diagn Mol Pathol. 2005 Dec;14(4):213-23.
Colomer A, Erill N, Vidal A, Calvo M, Roman R, Verdu M, Cordon-Cardo C, Puig X.
BIOPAT, Grup Assistencia, Barcelona.
Irinotecan (CPT-11) combined with bolus 5-fluo- rouracil/leucovorin (Saltz regimen) as first-line chemotherapy of patients with advanced colo- rectal cancer.
Anticancer Drugs. 2006 Jan;17(1):89-94.
Barcelo R, López Vivanco G, Rivera F, García Girón C, Alonso M, Castañón C, Ramos M, Navalón M, Centelles M, Balcells M.
Hospital de Cruces Osakidetza, Barakaldo- Vizcaya.
Interleukin-2 for the treatment of solid tumors other than melanoma and renal cell carcinoma.
Anticancer Drugs. 2006 Jan;17(1):1-12.
Grande C, Firvida JL, Navas V, Casal J.
Department of Medical Oncology, Vigo University Hospital Complex, Vigo.
Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer.
Cancer Chemother Pharmacol. 2005 Nov 25;:1-6 de Carpeno JC, Baron MG, Aguilar J, Chacón JI, Feliu J, García MJ, Madroñal C, Colmenarejo A, Sanchez JJ, Ordoñez A; The Oncopaz Cooperative Group (Spain).
Department of Medical Oncology, La Paz, Madrid.
Prospective study of resting energy expenditure changes in head and neck cancer patients trea- ted with chemoradiotherapy measured by indi- rect calorimetry.
Nutrition. 2005 Nov-Dec;21(11-12):1107-12.
and/or metastatic squamous cell carcinoma of the head and neck.
Cancer. 2006 Jan 1;106(1):106-11.
Hitt R, Amador ML, Quintela-Fandino M, Jimeno A, Del Val O, Hernando S, Cortes-Funes H.
Department of Medical Oncology, Hospital Universitario Doce de Octubre, Madrid.
Molecular pathology of endometrial carcinoma:
transcriptional signature in endometrioid tumors.
Histol Histopathol. 2006 Feb;21(2):197-204.
Abal M, Planaguma J, Gil-Moreno A, Monge M, Gonzalez M, Baro T, Garcia A, Castellvi J, Ramon Y Cajal S, Xercavins J, Alameda F, Reventos J.
Unitat de Recerca Biomedica, Vall d'Hebron Research Institute University Hospital, Barcelona.
ATM gene expression is associated with diffe- rentiation and angiogenesis in infiltrating breast carcinomas.
Histol Histopathol. 2006 Feb;21(2):149-56.
Cuatrecasas M, Santamaria G, Velasco M, Camacho E, Hernandez L, Sanchez M, Orrit C, Murcia C, Cardesa A, Campo E, Fernandez PL.
Department of Pathology, Vall d'Hebron University Hospital, Barcelona.
The contributions of Santiago Ramon y Cajal to cancer research - 100 years on.
Nat Rev Cancer. 2005 Nov;5(11):904-9.
Martinez A, Marin VG, Junquera SR, Martinez- Murillo R, Freire M.
Department of Neuroanatomy and Cell Biology, Instituto Cajal, CSIC, Madrid.
Risk factors for pediatric malignant bone tumors.
An Pediatr (Barc). 2005 Dec;63(6):537-47.
Spanish.
Ferris I Tortajada J, Berbel Tornero O, Ortega Garcia J, Claudio-Morales L, Garcia I Castell J, Marti Perales V, Miranda Casas L.
Unidad de Salud Medioambiental Pediatrica.
Seccion de Oncologia Pediatrica. Hospital Materno-Infantil Universitario La Fe. Valencia.
Update of the treatment of advanced prostate cancer and management of its complications Med Clin (Barc). 2005 Nov 12;125(17):671-8.
Spanish.
Gil-Bazo I, Ignacio Martinez-Salamanca J, Bianco Jr FJ.
Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, USA.
Evaluating HapMap SNP data transferability in a large-scale genotyping project involving 175 cancer-associated genes.
Hum Genet. 2005 Dec 2;:1-11
Ribas G, Gonzalez-Neira A, Salas A, Milne RL, Vega A, Carracedo B, Gonzalez E, Barroso E, Fernandez LP, Yankilevich P, Robledo M, Carracedo A, Benitez J.
Grupo de Genética Humana Programa de Patología Molecular, Centro Nacional de
García-Peris P, Lozano MA, Velasco C, de La Cuerda C, Iriondo T, Breton I, Camblor M, Navarro C.
Nutrition Unit, Hospital General Universitario Gregorio Marañón, Madrid.
Polymer conjugates: nanosized medicines for tre- ating cancer.
Trends Biotechnol. 2006 Jan;24(1):39-47. Epub 2005 Nov 22.
Vicent MJ, Duncan R.
Centre for Polymer Therapeutics, Welsh School of Pharmacy, Cardiff University, Cardiff, UK; Centro de Investigación Principe Felipe-FVIB, Valencia.
Subdermal re-injection: a method to increase surgical detection of the sentinel node in breast cancer without increasing the false-negative rate.
Eur J Nucl Med Mol Imaging. 2005 Nov 24;
Bajen MT, Benitez A, Mora J, Ricart Y, Ferran N, Guirao S, Carrera D, Gil M, Pla MJ, Guma A, Palacin JA, Martin-Comin J.
Department of Nuclear Medicine, Breast Unit, Hospital Universitari de Bellvitge - IDIBELL, Barcelona.
Relevance of multidrug resistance proteins on the clinical efficacy of cancer therapy.
Curr Drug Deliv. 2004 Jul;1(3):203-12.
Merino V, Jimenez-Torres NV, Merino-Sanjuan M.
Departamento de Farmacia y Tecnologia Farmaceutica, Faculty of Pharmacy, University of Valencia, Valencia.
An MDR-EGFP gene fusion allows for direct cellu- lar localization, function and stability assessment of P-glycoprotein.
Curr Drug Deliv. 2004 Jan;1(1):43-56.
Petriz J, Gottesman MM, Aran JM.
Servei d'Hematerapia i Hemostasia, Institut d'Investigacions Biomediques August Pi i Sunyer (DIBAPS), Hospital Clinic, Universitat de Barcelona Villarroel, Barcelona.
Giant renal oncocytoma
Actas Urol Esp. 2005 Sep;29(8):791-3. Spanish.
Alvarez Ardura M, Hernandez Canas V, de la Morena Gallego JM, Rengifo Abbad D, Gonzalez-Chamorro Ladron de Guevara F, Llorente Abarca C.
Servicio de Urología, Fundación Hospital de Alcorcón, Madrid.
Anti-apoptotic potencial role of p38 in prostate cancer
Actas Urol Esp. 2005 Sep;29(8):769-76. Spanish.
Ricote Belinchon M, Bethencourt Codes FR, Garcia-Tunon Llanio I, Fraile Laiz B, Fernandez Saez C, Aller Tresguerres P, Gonzalez-Garcia J, Vera San Martin R, Paniagua Gomez-Alvarez R, Royuela Garcia M.
Departamento de Biología Celular y Genética, Universidad de Alcalá, Madrid.
Effect of polyphenols in the Mediterranean diet on proliferation and mediators of in vitro inva- siveness of the MB-49 murine bladder cancer cell line
public aciones
Section of Gastrointestinal Surgery, Hospital Universitari del Mar, Universitat Autonóma de Barcelona, Barcelona.
Mismatch repair status in the prediction of bene- fit from adjuvant fluorouracil chemotherapy on colorectal cancer.
Gut. 2005 Nov 18.
Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, Pinol V, Xicola RM, Bujanda L, Rene JM, Clofent J, Bessa X, Morillas JD, Nicolas-Perez D, Paya A, Alenda C.
Department of Gastroenterology, Hospital General Universitario, Alicante.
Cell cycle arrest and proapoptotic effects of the anticancer cyclodepsipeptide serratamolide (AT514) are independent of p53 status in breast cancer cells.
Biochem Pharmacol. 2005 Dec 19;71(1-2):32- 41. Epub 2005 Nov 18.
Soto-Cerrato V, Montaner B, Martinell M, Vilaseca M, Giralt E, Perez-Tomas R.
Department of Pathology and Experimental Therapeutics, Cancer Cell Biology Research Group, Universitat de Barcelona, L'Hospitalet, Barcelona.
Results of a series of transrectal ultrasound gui- ded biopsy of the prostate in 6000 patients. Part II: PSA derived parameters
Arch Esp Urol. 2005 Sep;58(7):623-34.
Rodriguez-Patron Rodriguez R, Mayayo Dehesa T, Burgos Revilla FJ, Alonso Gonzalez M, Lennie Zucharino A, Garcia Gonzalez R.
Unidad de Ecografia Urológica, Universidad de Alcalá de Henares, Madrid.
Results of a series of transrectal ultrasound gui- ded biopsy of the prostate in 6000 patients. Part I: pathology, digital rectal examination, transrec- tal ultrasound, and PSA
Arch Esp Urol. 2005 Sep;58(7):611-22.
Rodríguez-Patrón Rodríguez R, Mayayo Dehesa T, Alonso González M, Burgos Revilla FJ, Lennie Zucharino A.
Unidad de Ecografía Urológica, Técnico de Salud Área 8, Madrid.
Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to pre- dict the outcome of patients.
Eur J Haematol. 2005 Nov 18.
Plancarte F, López-Guillermo A, Arenillas L, Montoto S, Gine E, Muntanola A, Ferrer A, Villamor N, Bosch F, Colomo L, Balaguer O, Campo E, Montserrat E.
Department of Hematology, Hospital Clinic, Barcelona.
Tat8-TK/GCV Suicide Gene Therapy Induces Pancreatic Tumor Regression In Vivo.
Hum Gene Ther. 2005 Nov 17
Cascante A, Huch M, Rodríguez LG, González JR, Costantini L, Fillat C.
Programa Gens i Malaltia, Centre de Regulacio Actas Urol Esp. 2005 Sep;29(8):743-9. Spanish.
Garcia Mediero JM, Ferruelo Alonso A, Paez Borda A, Lujan Galan M, Angulo Cuesta J, Chiva Robles V, Berenguer Sanchez A.
Servicio de Urología, Hospital Universitario de Getafe, Madrid.
Pediatric paraganglioma: An early manifesta- tion of an adult disease secondary to germline mutations.
Pediatr Blood Cancer. 2005 Nov 22.
Mora J, Cascon A, Robledo M, Catala A.
Laboratori de biologia molecular dels tumors del desenvolupament i Oncologia Pediatrica, Hospital Sant Joan de Deu de Barcelona.
Sinus histiocytosis with massive lymphadeno- pathy (Rosai-Dorfman disease) treated with 2- chlorodeoxyadenosine.
Pediatr Blood Cancer. 2005 Nov 21;
Tasso M, Esquembre C, Blanco E, Moscardo C, Niveiro M, Paya A.
Division of Pediatric Oncology, Hospital General Universitario de Alicante, Alicante.
Functional Fas (Cd95/Apo-1) promoter poly- morphisms in inbred mouse strains exhibiting different susceptibility to gamma-radiation-indu- ced thymic lymphoma.
Oncogene. 2005 Nov 21.
Villa-Morales M, Santos J, Fernandez-Piqueras J.
Laboratorio de Genética Molecular Humana, Departamento de Biología, Universidad Autónoma de Madrid, Madrid.
The future development of bevacizumab in colo- rectal cancer.
Oncology. 2005;69 Suppl 3:34-45. Epub 2005 Nov 21. Review.
Diaz-Rubio E, Schmoll HJ.
Servicio de Oncología, Hospital Clínico Universitario San Carlos, Madrid.
Introduction. Critical role of anti-angiogenesis and VEGF inhibition in colorectal cancer.
Oncology. 2005;69 Suppl 3:1-3. Epub 2005 Nov 21. Review.
Diaz-Rubio E, Schmoll HJ.
Servicio de Oncología, Hospital Clínico Universitario San Carlos, Madrid.
Antibody-based antiangiogenic cancer therapy.
Expert Opin Ther Targets. 2005 Dec;9(6):1235- 45.
Sanz L, Alvarez-Vallina L.
Department of Immunology, Hospital Universitario Clínica Puerta de Hierro, Madrid.
Diagnostic radiology and nuclear medicine.
J Surg Oncol. 2005 Dec 1;92(3):191-202.
Review.
Castillo E, Lawler LP.
Instituto Radiológico Castillo, Madrid.
Epidemiology of esophageal adenocarcinoma.
J Surg Oncol. 2005 Dec 1;92(3):151-9. Review.
Pera M, Manterola C, Vidal O, Grande L.
Genomica-CRG-UPF, Barcelona.
HER-2 gene amplification by chromogenic in situ hybridisation (CISH) compared with fluorescence in situ hybridisation (FISH) in breast cancer-A study of two hundred cases.
Breast. 2005 Nov 11.
Saez A, Andreu FJ, Segui MA, Bare ML, Fernandez S, Dinares C, Rey M.
Department of Pathology, UDIAT Centre Diagnostic-Corporacio Parc Tauli, Sabadell, Barcelona.
Dual role of LOH at MMR loci in hereditary non- polyposis colorectal cancer?
Oncogene. 2005 Nov 14.
Sánchez de Abajo A, de la Hoya M, van Puijenbroek M, Godino J, Díaz-Rubio E, Morreau H, Caldés T.
Laboratory of Molecular Oncology, Hospital Clínico San Carlos, Madrid.
Mechanisms of inactivation of the receptor tyrosi- ne kinase EPHB2 in colorectal tumors.
Cancer Res. 2005 Nov 15;65(22):10170-3.
Alazzouzi H, Davalos V, Kokko A, Domingo E, Woerner SM, Wilson AJ, Konrad L, Laiho P, Espin E, Armengol M, Imai K, Yamamoto H, Mariadason JM, Gebert JF, Aaltonen LA, Schwartz S Jr, Arango D.
Molecular Oncology and Aging Group, Molecular Biology and Biochemistry Research Center (CIB- BIM), Valle Hebrón Hospital Research Institute, Barcelona.
Cancer incidence in a general population of asth- ma patients.
Pharmacoepidemiol Drug Saf. 2005 Nov 15.
González-Perez A, Fernández-Vidaurre C, Rueda A, Rivero E, García Rodríguez LA.
Centro Español de Investigación Farmacoepidemiológica (CEIFE), Madrid.
Survival of mycosis fungoides in patients in the Southeast of England.
Dermatology. 2005;211(4):325-9.
Morales MM, Putcha V, Evans HS, Olsen J, Llopis A, Moller H.
Unit of Public Health and Environmental Care, Department of Preventive Medicine, University of Valencia, Valencia.
Conservative management of epithelial ovarian cancer.
Eur J Gynaecol Oncol. 2005;26(5):473-8. Review.
Dexeus S, Labastida R, Dexeus D.
Department of Obstetrics and Gynecology, Institut Universitari Dexeus University of Barcelona, Barcelona.
The role of radiotherapy in the management of bucopharyngeal epidemic Kaposi's sarcoma Acta Otorrinolaringol Esp. 2005 Oct;56(8):
368-72.
Andreu Martínez FJ, Martínez Mateu JM.
Servicio de Oncología Radioterápica, Hospital Universitari Sant Joan, Sant Joan d'Alacant,
public a ciones
Department of Physiology, School of Medicine, University of Santiago de Compostela, Madrid.
Hepatoportal sclerosis and liver angiosarcoma:
an infrequent association with a possible com- mon etiology]
Gastroenterol Hepatol. 2005 Nov;28(9):555-7.
Sanz - García C, Matilla-Pena A, Nogales-Rincón O, Nunez-Martínez O, Clemente-Ricote G.
Servicio de Aparato Digestivo, Hospital General Universitario Gregorio Marañón, Madrid.
Trastuzumab associated with successive cytotoxic therapies beyond disease progression in metas- tatic breast cancer.
Clin Breast Cancer. 2005 Oct;6(4):325-9.
García-Saenz JA, Martín M, Puente J, López- Tarruella S, Casado A, Moreno F, Grande E, Díaz-Rubio E.
Servicio de Oncología Médica, Hospital Clínico San Carlos, Madrid.
Spinal subarachnoid hematoma after lumbar puncture in a patient with leukemia: report of a case and review of the literature.]
Neurocirugía (Astur). 2005 Oct;16(5):447-52.
Ayerbe J, Quinones D, Prieto E, Sousa P.
Fundación Jiménez Díaz. Madrid.
Phase III study comparing cisplatin plus fluorou- racil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemora- diotherapy in locally advanced head and neck cancer.
J Clin Oncol. 2005 Dec 1;23(34):8636-45. Epub 2005 Nov 7.
Hitt R, Lopez-Pousa A, Martinez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Marti JL, Lobo F, Pastor P, Valenti V, Belon J, Sanchez MA, Chaib C, Pallares C, Antón A, Cervantes A, Paz- Ares L, Cortés-Funes H.
Servicio de Oncología Médica, Hospital Universitario 12 de Octubre de Madrid.
Comparative genomic hybridization analysis of cutaneous large B-cell lymphomas.
Exp Dermatol. 2005 Dec;14(12):883-90.
Giménez S, Costa C, Espinet B, Solé F, Pujol RM, Puigdecanet E, García-Moreno P, Sánchez J, Gallardo F, Estrach T, García-Muret P, Romagosa V, Serrano S, Servitje O.
Laboratori de Citogenetica i Biologia Molecular, Servei de Patologia, Hospital del Mar (IMAS), Unitat de Recerca en Neoplasies Hematologiques, PRBB, Barcelona.
Doxazosin induces apoptosis in LNCaP prostate cancer cell line through DNA binding and DNA- dependent protein kinase down-regulation.
Int J Oncol. 2005 Dec;27(6):1617-23.
Arencibia JM, Del Rio M, Bonnin A, Lopes R, Lemoine NR, López-Barahona M.
Departamento de Bioquimica, Facultad de CC.
Biosanitarias, Universidad Francisco de Victoria, Madrid.
Cholinesterase activity of human lung tumours varies according to their histological classification.
Alicante.
Total and specific fluid consumption as determi- nants of bladder cancer risk.
Int J Cancer. 2005 Nov 11;
Villanueva CM, Cantor KP, King WD, Jaakkola JJ, Cordier S, Lynch CF, Porru S, Kogevinas M.
Respiratory and Environmental Health Research Unit, Institut Municipal d'Investigacio Medica (IMIM), Barcelona.
Heterogeneity of prognostic profiles in non- small cell lung cancer: too many variables but a few relevant.
Eur J Epidemiol. 2005;20(11):907-14.
Gómez de la Cámara A, López-Encuentra A, Ferrando P; Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumolody and Thoracic Surgery (GCCB-S).
Unidad de Investigación-Epidemiológica Clínica, Hospital 12 de Octubre, Madrid.
Influence of thyroid hormone receptors on bre- ast cancer cell proliferation.
Ann Oncol. 2006 Jan;17(1):60-4. Epub 2005 Nov 9.
Conde I, Paniagua R, Zamora J, Blanquez MJ, Fraile B, Ruiz A, Arenas MI.
Department of Cell Biology and Genetics, University of Alcalá, Alcalá de Henares, Madrid.
Analysis of the candidate tumor suppressor Ris- 1 in primary human breast carcinomas.
Mutat Res. 2005 Nov 5.
Silva J, Silva JM, Barradas M, Garcia JM, Domínguez G, Garcia V, Pena C, Gallego I, Espinosa R, Serrano M, Bonilla F.
Department of Medical Oncology, Hospital Universitario Puerta de Hierro, Madrid.
Role of metalloproteinases MMP-9 and MT1- MMP in CXCL12-promoted myeloma cell inva- sion across basement membranes.
J Pathol. 2006 Jan;208(1):108-18.
Parmo-Cabanas M, Molina-Ortiz I, Matías- Román S, García-Bernal D, Carvajal-Vergara X, Valle I, Pandiella A, Arroyo AG, Teixido J.
Department of Immunology, Centro de Investigaciones Biológicas, CSIC, Madrid.
Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to bio- chemical relapse.
Br J Cancer. 2005 Nov 28;93(11):1285-94.
Domingo-Domenech J, Mellado B, Ferrer B, Truan D, Codony-Servat J, Sauleda S, Alcover J, Campo E, Gascon P, Rovira A, Ross JS, Fernandez PL, Albanell J.
Department of Medical Oncology, Hospital Clinic
& Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona.
Plitidepsin has a cytostatic effect in human undifferentiated (anaplastic) thyroid carcinoma.
Clin Cancer Res. 2005 Nov 1;11(21):7664-73.
Bravo SB, García-Rendueles ME, Seoane R, Dosil V, Cameselle-Teijeiro J, López-Lazaro L, Zalvide J, Barreiro F, Pombo CM, Alvarez CV.
Carcinogenesis. 2005 Nov 5;
Martínez-Moreno P, Nieto-Cerón S, Torres-Lanzas J, Ruíz-Espejo F, Tovar-Zapata I, Martínez- Hernández P, Rodríguez-López JN, Vidal CJ, Cabezas-Herrera J.
Servicio de Análisis Clínicos, University Hospital Virgen de la Arrixaca, Murcia; Departamento de Bioquímica y Biología Molecular-A, Facultad de Biología, Universidad de Murcia.
Genome-wide differences between microsatellite stable and unstable colorectal tumors.
Carcinogenesis. 2005 Nov 4.
Camps J, Armengol G, Del Rey J, Lozano J, Vauhkonen H, Prat E, Egozcue J, Sumoy L, Knuutila S, Miro R.
Departament de Biologia Cellular, Fisiologia i Immunologia and Institut de Biotecnologia i de Biomedicina, Universitat Autonoma de Barcelona, Bellaterra.
Low prevalence of germline hMSH6 mutations in colorectal cancer families from Spain.
World J Gastroenterol. 2005 Oct 7;11(37):
5770-6.
de Abajo AS, de la Hoya M, Tosar A, Godino J, Fernández JM, Asenjo JL, Villamil BP, Segura PP, Díaz-Rubio E, Caldés T.
Laboratorio de Oncología Molecular, Hospital Clínico San Carlos, Madrid.
Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas.
Leukemia. 2005 Dec;19(12):2254-63.
Martínez-Delgado B, Cuadros M, Honrado E, Ruiz de la Parte A, Roncador G, Alvés J, Castrillo JM, Rivas C, Benitez J.
Human Genetics Department, Centro Nacional de Investigaciones Oncologicas (CNIO), Madrid.
RB1 gene mutation up-date, a meta-analysis based on 932 reported mutations available in a searchable database.
BMC Genet. 2005 Nov 4;6:53.
Valverde JR, Alonso J, Palacios I, Pestana A.
Servicio de Informática, Centro Nacional de Biotecnología, CSIC, Madrid.
Unexpected roles for pRb in mouse skin carcino- genesis.
Cancer Res. 2005 Nov 1;65(21):9678-86.
Ruiz S, Santos M, Lara MF, Segrelles C, Ballestin C, Paramio JM.
Program on Cell and Molecular Biology, Centro de Investigaciones Energeticas Medioambientales y Tecnologicas and Department of Pathology, Hospital 12 de Octubre, Madrid.
Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1.
Prog Lipid Res. 2005 Nov;44(6):345-56. Epub 2005 Oct 10.
Soriano JM, Gonzalez L, Catala AI.
Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Valencia.
Evaluation of the antitumor activity of interleu-
public aciones
Antisense gene therapy using anti-k-ras and antitelomerase oligonucleotides in colorectal cancer.
Rev Esp Enferm Dig. 2005 Jul;97(7):472-80.
English, Spanish.
Lledo S, Alfonso R, Alino SF.
Department of General and Digestive Surgery, Hospital Clínico Universitario, Universidad de Valencia, Valencia.
Risk-adapted management for patients with cli- nical stage I seminoma: the second Spanish Germ Cell Cancer Cooperative Group study.
J Clin Oncol. 2005 Dec 1;23(34):8717-23. Epub 2005 Oct 31.
Aparicio J, Germa JR, Garcia del Muro X, Maroto P, Arranz JA, Saenz A, Barnadas A, Dorca J, Guma J, Olmos D, Bastus R, Carles J, Almenar D, Sanchez M, Paz-Ares L, Satrustegui JJ, Mellado B, Balil A, Lopez-Brea M, Sanchez A.
Department of Medical Oncology, Hospital Universitario La Fe, Valencia.
Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indo- lent form of a mantle cell lymphoma?
Hum Pathol. 2005 Nov;36(11):1232-7.
Espinet B, Sole F, Pedro C, Garcia M, Bellosillo B, Salido M, Florensa L, Camacho FI, Baro T, Lloreta J, Serrano S.
Servei de Patologia (Laboratori de Citogenetica i Biologia Molecular, Laboratori de Citologia Hematologica, Laboratori de Patologia), Hospital del Mar, IMAS, URNHE, PRBB, Barcelona.
Ultrastructural studies in a series of 18 cases of chromophobe renal cell carcinoma.
Ultrastruct Pathol. 2005 Sep-Oct;29(5):377-87.
Moreno SM, Benitez IA, Martinez Gonzalez MA.
Departamento de Anatomia Patologica, Hospital Universitario 12 de Octubre, Madrid.
Studies of interaction of trichloro{eta(2)-cis-N,N- dimethyl-1-[6-(N',N'-dimethyl-ammonium- methyl)-cyclohex-3-ene-1-yl]-methylammonium}p latinum(II) chloride with DNA: Effects on secon- dary and tertiary structures of DNA. Cytotoxic assays on human ovarian cancer cell lines, resis- tant and non-resistant to cisplatin.
Bioorg Med Chem. 2005 Oct 24.
Gay M, Montana AM, Moreno V, Prieto MJ, Perez JM, Alonso C.
Department of Organic Chemistry, Universidad de Barcelona, Barcelona; Department of Inorganic Chemistry, Universidad de Barcelona, Barcelona.
Studies of interaction of dichloro[eta2-dimethyl- (2-methylidene-cyclohexylmethyl)-amino]plati- num(II) with DNA: effects on secondary and tertiary structures of DNA - cytotoxic assays on human cancer cell lines Capan 1 and A431.
J Inorg Biochem. 2005 Dec;99(12):2387-94.
Epub 2005 Oct 26.
Gay M, Montana AM, Moreno V, Prieto MJ, Llorens R, Ferrer L.
kin-12 in an experimental murine model of colo- rectal cancer induced by 1,2 dimethyl-hydrazine (DMH).
Rev Esp Enferm Dig. 2005 Sep;97(9):619-28.
English, Spanish.
Coca S, Enrech S, Moreno Garcia V, Saez MA, Gutierrez C, Colmenarejo A, Hernandez JM, Perez Piqueras J.
Department of Pathology, Hospital Central de la Defensa Gomez Ulla, School of Medicine, Universidad Complutense, Madrid.
Tracheo-esophageal fistula in a patient with esophageal cancer and stent.
Rev Esp Enferm Dig. 2005 Aug;97(8):600-1.
English, Spanish.
Macia Escalante S, Molina Garrido MJ, Martinez Ortiz MJ, Ballester Navarro I, Martin Ureste M, Guillen Ponce C, Carrato Mena A.
Service of Oncology, Hospital General Universitario, Elche, Alicante.
Phase II randomised trial of raltitrexed-oxalipla- tin vs raltitrexed-irinotecan as first-line treatment in advanced colorectal cancer.
Br J Cancer. 2005 Nov 28;93(11):1230-5.
Feliu J, Castanon C, Salud A, Mel JR, Escudero P, Pelegrin A, Lopez-Gomez L, Ruiz M, Gonzalez E, Juarez F, Lizon J, Castro J, Gonzalez-Baron M;
Oncopaz Cooperative Group, Spain.
Service of Medical Oncology, La Paz, Madrid.
Does epidermal growth factor receptor status predict activity of cetuximab in colorectal cancer patients?
Nat Clin Pract Oncol. 2005 Jun;2(6):284-5.
Baselga J.
Department of Oncology, Vall d'Hebron University Hospital, Barcelona.
Is fecal DNA testing superior to fecal occult-blood testing for colorectal cancer screening?
Nat Clin Pract Oncol. 2005 May;2(5):234-5.
Capella G.
Translational Research Laboratory, Institut Catala d'Oncologia, Barcelona.
Intraoral tumor with rapid growing. Report of a case.
Med Oral Patol Oral Cir Bucal. 2005 Nov- Dec;10(5):440-3. English, Spanish.
Gonzalez-Martin-Moro J, Cebrian-Carretero JL, Gomez-Garcia E, del Castillo-Pardo de Vera JL, del Val D.
Servicio de Cirugía Oral y Maxilofacial, Hospital Universitario La Paz, Madrid.
Assessing quality of end-of-life hospital care in a southern European regional health service.
Int J Technol Assess Health Care. 2005 Fall;21(4):464-70.
Aldasoro E, Alonso AP, Ribacoba L, Esnaola S, Olaizola M, Carrera JA, Banuelos A, Rico R.
Service of Studies and Research, Department of Health of the Basque Government, Donostia-San Sebastian, Vitoria-Gasteiz.
Departamento de Química Orgánica, Universidad de Barcelona, Facultad de Química, Barcelona.
Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature.
J Viral Hepat. 2005 Nov;12(6):648-54. Review.
Ramos-Casals M, Pares A, Jara LJ, Solans R, Vinas O, Vazquez P, Sanchez-Tapias JM, Rodes J, Font J; HISPAMEC Study Group*.
Department of Autoimmune Diseases, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Hospital Clinic, School of Medicine, University of Barcelona, Barcelona.
An unexpected wide population variation of the G1733A polymorphism of the androgen receptor gene: data on the Mediterranean region.
Am J Hum Biol. 2005 Nov-Dec;17(6):690-5.
Esteban E, Via M, Gonzalez-Perez E, Santamaria J, Dugoujon JM, Vona G, Harich N, Luna F, Saetta AA, Bissar N, Moral P.
Department of Animal Biology-Anthropology, Faculty of Biology, University of Barcelona, Barcelona.
Improvement of breast cancer relapse prediction in high risk intervals using artificial neural net- works.
Breast Cancer Res Treat. 2005 Dec;94(3):265-72.
Jerez JM, Franco L, Alba E, Llombart-Cussac A, Lluch A, Ribelles N, Munarriz B, Martin M.
Departamento de Lenguajes y Ciencias de la Computación, Universidad de Málaga, Málaga.
Tumor markers in breast cancer- European Group on Tumor Markers recommendations.
Tumour Biol. 2005 Nov-Dec;26(6):281-93.
Review.
Molina R, Barak V, van Dalen A, Duffy MJ, Einarsson R, Gion M, Goike H, Lamerz R, Nap M, Soletormos G, Stieber P.
Laboratory of Biochemistry, Hospital Clinic, Medical School, Barcelona.
beta-Catenin, Nf-kappaB and FAS protein expression are independent events in head and neck cancer: study of their association with clini- cal parameters.
Cancer Lett. 2005 Dec 8;230(1):141-8.
Rodriguez-Pinilla M, Rodriguez-Peralto JL, Hitt R, Sanchez JJ, Sanchez-Verde L, Alameda F, Ballestin C, Sanchez-Cespedes M.
Molecular Pathology Program, Spanish National Cancer Centre (CNIO), Madrid.
Response to the publication: EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.
Eur J Cancer. 2005 Dec;41(18):2789-91. Epub 2005 Oct 25.
Gascon P, Ludwig H.
Hospital Clinic, Barcelona.
Pharmacological intervention of cyclooxygenase- 2 and 5-lipoxygenase pathways. Impact on inflammation and cancer.
public a ciones
Servicio de Medicina Interna, Hospital Universitario Germans Trias i Pujol, Facultat de Medicina, Universitat Autónoma de Barcelona, Barcelona.
The novel DNA methylation inhibitor zebulari- ne is effective against the development of murine T-cell lymphoma.
Blood. 2005 Oct 20.
Herranz M, Martin-Caballero J, Fraga MF, Ruiz-Cabello J, Flores JM, Desco M, Marquez V, Esteller M.
Cancer Epigenetics Laboratory, Spanish National Cancer Centre (CNIO), Madrid.
Cranial nerve paralysis in a patient with pros- tate cancer and bone metastases
Clin Transl Oncol. 2005 Oct;7(9):414-6.
Spanish.
Macia Escalante S, Guillen Ponce C, Molina Garrido MJ, Martinez Ortiz MJ, Ballester Navarro I, Carrato Mena A.
Servicio de Oncología Médica, Hospital General Universitario de Elche, Elche, Alicante.
Single fraction boost with high dose rate interstitial brachytherapy in conservative treat- ment of breast carcinoma
Clin Transl Oncol. 2005 Oct;7(9):404-8.
Spanish.
Beato Tortajada I, Guinot Rodriguez JL, Arribas Alpuente L, Aguayo Martos M, Carrascosa Perez M, Tortajada Azcutia M, Escolar Perez PP, Maronas Martin M, Chust Vicente M, Mengual Cloquell JL, Pesudo Ayet C, Casana Giner M.
Instituto Valenciano de Oncología, Valencia.
Prevention of cervical cancer
Aten Primaria. 2005 Oct 15;36(6):328-33.
Spanish.
Marzo-Castillejo M, Cierco Peguero P, del Cura Gonzalez I.
Divisio de Atencio Primaria, Institut Catala de la Salut, Grupo de Cancer PAPPS-semFYC, Barcelona.
Non-homologous end-joining defect in fanconi anemia hematopoietic cells exposed to ioni- zing radiation.
Radiat Res. 2005 Nov;164(5):635-41.
Casado JA, Nunez MI, Segovia JC, Ruiz de Almodovar JM, Bueren JA.
Allergy and Clinical Immunology Section, Paediatrics Department, Integrated Unit Sant Joan de Deu--Clinic, Hospital Universitari Sant Joan de Deu, Universitat de Barcelona, Barcelona.
A novel multiplexing, polymerase chain reac- tion-based assay for the analysis of chromoso- me 18q status in colorectal cancer.
J Mol Diagn. 2005 Oct;7(4):478-85.
Erill N, Colomer A, Calvo M, Vidal A, Roman R, Verdu M, Cordon-Cardo C, Puig X.
Biopat, Universitat de Barcelona, Barcelona.
Survival of 2,991 patients with surgical lung Curr Pharm Des. 2005;11(26):3431-47. Review.
Claria J, Romano M.
BCLC Group. Liver Unit. Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona.
Telomerase activity as a prognostic factor in colorectal cancer.
Onkologie. 2005 Nov;28(11):553-7.
Sanz-Casla MT, Vidaurreta M, Sanchez-Rueda D, Maestro ML, Arroyo M, Cerdan FJ.
Laboratory, Tumor Biology Department, Madrid.
Latest advances and research in lung cancer.
Drug News Perspect. 2005 Jul-Aug;18(6):
405-11.
Thompson E.
Medical Information Department, Prous Science, Barcelona.
Disruption of the Fanconi anemia/BRCA path- way in sporadic cancer.
Cancer Lett. 2005 Oct 20.
Lyakhovich A, Surralles J.
Group of Mutagenesis, Department of Genetics and Microbiology, Universitat Autonoma de Barcelona, Barcelona.
Dietary intake of polycyclic aromatic hydrocar- bons in a Spanish population.
J Food Prot. 2005 Oct;68(10):2190-5.
Ibanez R, Agudo A, Berenguer A, Jakszyn P, Tormo MJ, Sanchez MJ, Quiros JR, Pera G, Navarro C, Martinez C, Larranaga N, Dorronsoro M, Chirlaque MD, Barricarte A, Ardanaz E, Amiano P, Gonzalezi CA.
Unit of Epidemiology, Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Barcelona.
Differential features of colorectal cancers fulfi- lling Amsterdam criteria without involvement of the mutator pathway.
Clin Cancer Res. 2005 Oct 15;11(20):7304-10.
Llor X, Pons E, Xicola RM, Castells A, Alenda C, Pinol V, Andreu M, Castellvi-Bel S, Paya A, Jover R, Bessa X, Giros A, Roca A, Gassull MA;
Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.
Gastroenterology Department, Germans Trias i Pujol Hospital, Universitat Autonoma de Barcelona, Barcelona.
Management of the febrile neutropenic patient.
Int J Antimicrob Agents. 2005 Dec;26 Suppl 2:S120-2; discussion S133-40. Epub 2005 Oct 21.
Picazo JJ; Association for Health Research and Development (ACINDES).
Department of Clinical Microbiology, Hospital Universitario de San Carlos, Universidad Complutense de Madrid, Madrid.
Screening for occult cancer in patients with acute venous thromboembolism.
J Thromb Haemost. 2005 Nov;3(11):2389-90.
Monreal M.
cancer: the denominator effect in survival.
Chest. 2005 Oct;128(4):2274-81.
Duque JK, Lopez-Encuentra A, Porta RR;
Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery.
Pneumology Service, Hospital Universitario, Madrid.
Mammalian cyclin-dependent kinases.
Trends Biochem Sci. 2005 Nov;30(11):630-41.
Epub 2005 Oct 19.
Malumbres M, Barbacid M.
Molecular Oncology Programme, Centro Nacional de Investigaciones Oncológicas, Madrid.
Treatment with all-trans retinoic acid and anth- racycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.
J Clin Oncol. 2005 Oct 20;23(30):7632-40.
Ortega JJ, Madero L, Martin G, Verdeguer A, Garcia P, Parody R, Fuster J, Molines A, Novo A, Deben G, Rodriguez A, Conde E, de la Serna J, Allegue MJ, Capote FJ, González JD, Bolufer P, Gonzalez M, Sanz MA; PETHEMA Group.
Servicio de Hematología, Hospital Universitario La Fe, Valencia.
Immunohistochemical expression of DNA repair proteins in familial breast cancer diffe- rentiate BRCA2-associated tumors.
J Clin Oncol. 2005 Oct 20;23(30):7503-11.
Honrado E, Osorio A, Palacios J, Milne RL, Sanchez L, Diez O, Cazorla A, Syrjakoski K, Huntsman D, Heikkila P, Lerma E, Kallioniemi A, Rivas C, Foulkes WD, Nevanlinna H, Benitez J.
Human Genetics Department Centro Nacional Investigaciones Oncológicas, Madrid.
Evaluating erythropoietic agents for the treat- ment of anaemia in the oncology setting.
Eur J Cancer. 2005 Nov;41(17):2601-12. Epub 2005 Oct 14.
Gascon P.
Hospital Clinic, Division of Medical Oncology, IDIBAPS, Institut Clinic Malalties Hemato- Oncologiques (ICMHO), University of Barcelona, Barcelona.
A review of EGFR targeted therapy.
Clin Adv Hematol Oncol. 2003 Apr;1(4):218-9.
Baselga J.
Universidad Autónoma de Barcelona, Barcelona.
public aciones
Pedimos disculpas con antelación a los autores que no se puedan ver reflejados en la selección de artículos de esta sección. Limitaciones en la búsqueda pueden conllevar que no estén todos los que son. En el caso de que alguno de los socios detectase alguna falta o error, le agrade- ceríamos encarecidamente que nos enviasen conocimiento de la misma para subsanarlo en el siguiente número. Gracias
